Pfizer Seen Circling Agila With U.S. Drug Shortages
News | 17 August 2012
A shortage of injectable drugs in the U.S. means India's Strides Arcolab Ltd. (STR) could sell a division that makes generic cancer treatments and antibiotics for more than the entire company's market value. Strides, which has seen its market ...
Click on the link to read the full article at Bloomberg
(This link will open in a new window)
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
